CELL-KINETICS - AN INDEPENDENT PROGNOSTIC VARIABLE IN STAGE-II MELANOMA OF THE SKIN

被引:9
作者
COSTA, A [1 ]
SILVESTRINI, R [1 ]
MEZZANOTTE, G [1 ]
VAGLINI, M [1 ]
GRIGNOLIO, E [1 ]
CLEMENTE, C [1 ]
CASCINELLI, N [1 ]
机构
[1] IST NAZL TUMORI, VIA VENEZIAN 1, I-20133 MILAN, ITALY
关键词
D O I
10.1038/bjc.1990.386
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic role of cell kinetics (expressed as 3H-thymidine labelling index,3H-TdR LI) was assessed on 145 patients with pathologic stage II melanoma subjected only to therapeutic lymph node dissection. The 3H-TdR LI determined on metastatic nodes was related to relapse-free survival and to survival. In particular, 3-year relapse-free survival was significantly different from patients with slowly and rapidly proliferating melanomas (40% vs 22%, P=0. 007), and this finding was consistently found for overall survival (68% vs 46%, P=0. 007). Moreover, in patients with high 3H-TdR LI tumours, the risk of relapse and death within the first year from lymphadenectomy was two-fold that of patients with low 3H-TdR LI tumours. Multiple regression analysis showed that 3H-TdR LI retained its prognostic significance on relapse-free and on overall survival even when the number of involved nodes and type of nodal metastases were considered. Present findings suggest that 3H-TdR LI can contribute to select high-risk stage II melanoma patients. © Macmillan Press Ltd., 1990.
引用
收藏
页码:826 / 829
页数:4
相关论文
共 34 条
[1]   A MULTIFACTORIAL ANALYSIS OF MELANOMA .3. PROGNOSTIC FACTORS IN MELANOMA PATIENTS WITH LYMPH-NODE METASTASES (STAGE-II) [J].
BALCH, CM ;
SOONG, SJ ;
MURAD, TM ;
INGALLS, AL ;
MADDOX, WA .
ANNALS OF SURGERY, 1981, 193 (03) :377-388
[2]  
BAUER KD, 1987, LAB INVEST, V57, P329
[3]   KI67 IMMUNOSTAINING IN PRIMARY BREAST-CANCER - PATHOLOGICAL AND CLINICAL ASSOCIATIONS [J].
BOUZUBAR, N ;
WALKER, KJ ;
GRIFFITHS, K ;
ELLIS, IO ;
ELSTON, CW ;
ROBERTSON, JFR ;
BLAMEY, RW ;
NICHOLSON, RI .
BRITISH JOURNAL OF CANCER, 1989, 59 (06) :943-947
[5]  
CADY B, 1984, ARCH SURG-CHICAGO, V119, P1067
[6]   FACTORS PROGNOSTIC FOR SURVIVAL IN PATIENTS WITH MALIGNANT-MELANOMA SPREAD TO THE REGIONAL LYMPH-NODES [J].
CALLERY, C ;
COCHRAN, AJ ;
ROE, DJ ;
REES, W ;
NATHANSON, SD ;
BENEDETTI, JK ;
ELASHOFF, RM ;
MORTON, DL .
ANNALS OF SURGERY, 1982, 196 (01) :69-75
[7]   PROGNOSIS OF SKIN MELANOMA WITH REGIONAL NODE METASTASES (STAGE-II) [J].
CASCINELLI, N ;
VAGLINI, M ;
NAVA, M ;
SANTINAMI, M ;
MAROLDA, R ;
ROVINI, D ;
CLEMENTE, C ;
BUFALINO, R ;
MORABITO, A .
JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (04) :240-247
[8]  
CHAUVEL P, 1988, RADIOTHER ONCOL, V547, P1
[9]  
CLARK WH, 1969, CANCER RES, V29, P705
[10]  
COSTA A, 1987, CANCER-AM CANCER SOC, V60, P2797, DOI 10.1002/1097-0142(19871201)60:11<2797::AID-CNCR2820601133>3.0.CO